GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Now Corp (OTCPK:NWPN) » Definitions » Return-on-Tangible-Equity

The Now (The Now) Return-on-Tangible-Equity : 0.00% (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is The Now Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. The Now's annualized net income for the quarter that ended in Sep. 2015 was $0.00 Mil. The Now's average shareholder tangible equity for the quarter that ended in Sep. 2015 was $-0.97 Mil. Therefore, The Now's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2015 was N/A%.

The historical rank and industry rank for The Now's Return-on-Tangible-Equity or its related term are showing as below:

NWPN's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.32
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

The Now Return-on-Tangible-Equity Historical Data

The historical data trend for The Now's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Now Return-on-Tangible-Equity Chart

The Now Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Return-on-Tangible-Equity
Get a 7-Day Free Trial - - -12.10 -12.70 -9.04

The Now Quarterly Data
Dec07 Dec08 Dec09 Dec10 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Sep14 Sep15
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.68 -19.74 -4.47 -0.02 -

Competitive Comparison of The Now's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, The Now's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Now's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Now's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where The Now's Return-on-Tangible-Equity falls into.



The Now Return-on-Tangible-Equity Calculation

The Now's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2013 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=-87.234/( (1007.952+921.165 )/ 2 )
=-87.234/964.5585
=-9.04 %

The Now's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2015 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2015 )  (Q: Sep. 2014 )(Q: Sep. 2015 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2015 )  (Q: Sep. 2014 )(Q: Sep. 2015 )
=0/( (0+-0.972)/ 1 )
=0/-0.972
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2015) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


The Now  (OTCPK:NWPN) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


The Now Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of The Now's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


The Now (The Now) Business Description

Traded in Other Exchanges
N/A
Address
3400 Pan American Drive, Unit 53, Miami, FL, USA, 33133
The Now Corp is a biopharmaceutical research company. The company focused on the research, education, and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purposes. It provides Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries.

The Now (The Now) Headlines